BRIEF published on 12/16/2025 at 21:23, 2 days 13 hours ago ABIONYX Pharma Announces €1.8 Million Capital Increase Capital Increase Subscription Rights Euronext Listing ABIONYX Pharma Financial Visibility
BRIEF published on 12/16/2025 at 21:23, 2 days 13 hours ago ABIONYX Pharma Annonce une Augmentation de Capital Augmentation De Capital Biopharmaceutique Levée De Fonds ABIONYX Pharma Sepsis
BRIEF published on 12/16/2025 at 21:23, 2 days 13 hours ago ABIONYX Pharma Announces a Capital Increase Fundraising Capital Increase Biopharmaceutical ABIONYX Pharma Sepsis
BRIEF published on 12/16/2025 at 21:23, 2 days 13 hours ago ABIONYX Pharma annonce une augmentation de capital de 1,8 million d'euros. Augmentation De Capital Cotation Euronext Visibilité Financière ABIONYX Pharma Droits D'abonnement
PRESS RELEASE published on 12/16/2025 at 21:18, 2 days 13 hours ago Informations privilégiées / Autres communiqués ABIONYX Pharma lance une augmentation de capital de 1,8M€ avec suppression du droit préférentiel de souscription à 3,10 euros par action et extension de la visibilité jusqu'à fin 2026 Augmentation De Capital Droit Préférentiel De Souscription ABIONYX Pharma Visibilité 3,10 Euros
PRESS RELEASE published on 12/16/2025 at 21:18, 2 days 13 hours ago Inside Information / Other news releases ABIONYX Pharma launches €1.8m capital increase with removal of preferential subscription rights, subscription price at 3.10 euros for new shares, extending financial visibility until 2026 Capital Increase Biopharma Preferential Subscription Rights ABIONYX Pharma Financial Visibility
BRIEF published on 12/05/2025 at 18:05, 13 days 16 hours ago ABIONYX Reports Monthly Voting Rights and Share Data Euronext Paris Share Capital Voting Rights AMF Regulations ABIONYX Pharma
BRIEF published on 12/05/2025 at 18:05, 13 days 16 hours ago ABIONYX publie des données mensuelles sur les droits de vote et les actions Euronext Paris Capital Social Droit De Vote ABIONYX Pharma Règlementation De L'AMF
PRESS RELEASE published on 12/05/2025 at 18:00, 13 days 16 hours ago Inside Information / Other news releases ABIONYX Pharma discloses monthly statement of total voting rights and shares as per French regulations. Company focused on innovative medicines in rare diseases Shares French Regulations Total Voting Rights ABIONYX Pharma Innovative Medicines
BRIEF published on 11/25/2025 at 18:38, 23 days 15 hours ago ABIONYX Pharma publie ses prévisions d'activité pour le troisième trimestre 2025 Mise À Jour Financière Revenu ABIONYX Pharma 3e Trimestre 2025 Recherche Sur La Septicémie
Published on 12/19/2025 at 03:15, 7 hours 15 minutes ago Tactical Resources Announces Receipt Of Final Order Approving Arrangement With Plum Acquisition Corp. III
Published on 12/19/2025 at 01:10, 9 hours 20 minutes ago Ostrom Climate Exits Existing UPRIIS ERPA Arrangements
Published on 12/19/2025 at 01:00, 9 hours 30 minutes ago Sun Peak Metals Announces Completion of Acquisition of Saudi Discovery Company SPV Limited
Published on 12/19/2025 at 00:50, 9 hours 40 minutes ago High Resolution Gravity Survey Targets Challenger Repeats
Published on 12/19/2025 at 00:00, 10 hours 30 minutes ago LIR Life Sciences Announces Appointment of Dr. Peter Singer as Scientific Advisor
Published on 12/19/2025 at 10:00, 30 minutes ago Partners Group to sell stake in Australian wind farm
Published on 12/19/2025 at 09:35, 55 minutes ago Top sports physio says football bosses failing to properly protect players' health this Christmas as injuries expected to rise
Published on 12/19/2025 at 09:31, 59 minutes ago Original-Research: THE NAGA GROUP AG (von NuWays AG): BUY
Published on 12/19/2025 at 09:26, 1 hour 4 minutes ago Original-Research: SYNBIOTIC SE (von NuWays AG): BUY
Published on 12/19/2025 at 09:21, 1 hour 9 minutes ago Original-Research: Netfonds AG (von NuWays AG): BUY
Published on 12/19/2025 at 08:30, 2 hours ago Share capital decrease by way of treasury shares cancellation
Published on 12/19/2025 at 08:30, 2 hours ago Réduction du capital par voie d’annulation d’actions propres
Published on 12/19/2025 at 07:00, 3 hours 30 minutes ago EURAZEO ANNONCE AVOIR MENÉ AVEC SUCCÈS UNE TRANSACTION ACCÉLÉRANT SA ROTATION D'ACTIFS
Published on 12/19/2025 at 07:00, 3 hours 30 minutes ago EURAZEO ANNOUNCES A SUCCESSFUL TRANSACTION ACCELERATING ITS ASSET ROTATION
Published on 12/18/2025 at 18:30, 16 hours ago Schneider Electric completes transaction to acquire remaining 35% stake in existing Indian JV
